Repros Therapeutics Inc Stock

Stocks

27/01/18	Repros Announces Negative Opinion From the EMA for Enclomiphene	GL
16/12/17	Repros Therapeutics Inc.® Receives Feedback Following an Oral Explanation with the European Medicines Agency	GL
13/12/17	REPROS THERAPEUTICS INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout	BU
12/12/17	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Repros Therapeutics Inc. to Allergan plc is Fair to Shareholders	BU
12/12/17	Repros Therapeutics Inc.® Announces Acquisition by Allergan plc	GL

02/04/15	Apple : Les valeurs à suivre sur les marchés américains
02/04/15	USA-Les valeurs à suivre à Wall Street

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
REPROS THERAPEUTICS INC	-.--%	+0.74%	-	-	0
LONZA GROUP AG	+2.08%	-0.99%	-1.03%	+11.57%	46.86B
REVOLUTION MEDICINES, INC.	-0.77%	+4.26%	+404.78%	+647.24%	40.23B
BEONE MEDICINES AG	+0.52%	+5.38%	+11.12%	+56.21%	36.23B
IQVIA HOLDINGS INC.	+1.59%	+3.97%	+7.20%	-5.60%	34.72B
CELLTRION, INC.	+0.62%	+1.65%	+5.41%	+43.89%	27.89B
MEDPACE HOLDINGS, INC.	-0.85%	+13.11%	+31.80%	+139.93%	16.79B
ASCENDIS PHARMA A/S	-0.02%	+1.31%	-	-	16.74B
EUROFINS SCIENTIFIC SE	+0.78%	-5.88%	+2.29%	+7.76%	13.12B
ICON PUBLIC LIMITED COMPANY	+1.51%	+1.77%	-10.83%	-30.01%	12.7B
Average	+0.49%	+0.97%	+56.34%	+108.87%	27.25B
Weighted average by Cap.	+0.62%	+1.05%	+76.43%	+138.78%